Loading…
Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis
SUMMARY We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF‐α and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF‐α and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular T...
Saved in:
Published in: | Clinical and experimental immunology 1995-08, Vol.101 (2), p.334-340 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73 |
---|---|
cites | cdi_FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73 |
container_end_page | 340 |
container_issue | 2 |
container_start_page | 334 |
container_title | Clinical and experimental immunology |
container_volume | 101 |
creator | ORTÍZ, A. ALONSO, J. GÓMEZ‐CHIARRI, M. LERMA, J. L. SERON, D. CONDOM, E. GONZÁLEZ, E. EGIDO, J. |
description | SUMMARY
We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF‐α and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF‐α and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular TNF‐α bioactivity coincided with maximal proteinuria. Rats treated with FN (5 mg/kg per 48 h) for 15 days had less proteinuria, glomerular and interstitial cell infiltration and glomerular PAF, TNF‐α and FN synthesis than non‐treated rats. In order to characterize further the mechanisms of action of FN, healthy rats were injected with either FN or saline. Peripheral blood mononuclear cells and neutrophils from healthy rats injected with FN secreted less TNF‐α and PAF, respectively, than those obtained from saline‐treated rats. Our data suggest that the beneficial effect of FN may be related to decreased number of glomerular leucocytes and decreased synthesis of inflammatory mediators and extracellular matrix. |
doi_str_mv | 10.1111/j.1365-2249.1995.tb08360.x |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1553248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77464144</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73</originalsourceid><addsrcrecordid>eNqVUkGO0zAUjRBoKANHQLIQQq1Eip04TswCNKomMNKosBjW1o_rtK7cOGMnZbrjCFyFFbfgEJwEh0YVbJDwxv5-77__bL0oekbwnIT1ajsnKcviJKF8TjjP5l2Fi5Th-d29aHKC7kcTjDGPOcH0YfTI-20oGWPJWXSWM1rkpJhE30tdOdso2ekGTcvlDK2UdAq88mht7E653oBDRnltG4-gWSF_aLpNqD2yNer6ne0dCgLODlc1yM66n1--gmk3gKY3yzIUP77NXqLWQKeM6gYwjNtDGLkeG9D040U5-y1fLlGw0jprdK1cIO3VyUkw2m6c7rR_HD2owXj1ZNzPo0_l5c3ifXz94d3V4uI6llnKcSwlZyuOi4JxCbICWOWSQUZ4ImmFMYGkoDzPw-dRAMZBVaSWSZ2mhSoSgDw9j94cddu-2qmVVE3nwIjW6R24g7Cgxd9IozdibfeCZFma0CIIvBgFnL3tle_ETnupjIFG2d6LPKeMEkoDcfpPIqGsSAua5CxQXx-pw6d7p-qTH4LFkBCxFUMMxBADMSREjAkRd6H56Z8vOrWOkQj48xEHL8HUDhqp_YmWMpLTLA20t0faZ23U4T8MiMXl1XBKfwFR5uDA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1468384276</pqid></control><display><type>article</type><title>Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis</title><source>PubMed Central (Open access)</source><creator>ORTÍZ, A. ; ALONSO, J. ; GÓMEZ‐CHIARRI, M. ; LERMA, J. L. ; SERON, D. ; CONDOM, E. ; GONZÁLEZ, E. ; EGIDO, J.</creator><creatorcontrib>ORTÍZ, A. ; ALONSO, J. ; GÓMEZ‐CHIARRI, M. ; LERMA, J. L. ; SERON, D. ; CONDOM, E. ; GONZÁLEZ, E. ; EGIDO, J.</creatorcontrib><description>SUMMARY
We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF‐α and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF‐α and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular TNF‐α bioactivity coincided with maximal proteinuria. Rats treated with FN (5 mg/kg per 48 h) for 15 days had less proteinuria, glomerular and interstitial cell infiltration and glomerular PAF, TNF‐α and FN synthesis than non‐treated rats. In order to characterize further the mechanisms of action of FN, healthy rats were injected with either FN or saline. Peripheral blood mononuclear cells and neutrophils from healthy rats injected with FN secreted less TNF‐α and PAF, respectively, than those obtained from saline‐treated rats. Our data suggest that the beneficial effect of FN may be related to decreased number of glomerular leucocytes and decreased synthesis of inflammatory mediators and extracellular matrix.</description><identifier>ISSN: 0009-9104</identifier><identifier>EISSN: 1365-2249</identifier><identifier>DOI: 10.1111/j.1365-2249.1995.tb08360.x</identifier><identifier>PMID: 7648718</identifier><identifier>CODEN: CEXIAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Biological and medical sciences ; Extracellular Matrix - drug effects ; Extracellular Matrix - metabolism ; fibronectin ; Fibronectins - biosynthesis ; Fibronectins - pharmacology ; Glomerular Mesangium - drug effects ; Glomerular Mesangium - metabolism ; Glomerulonephritis ; Glomerulonephritis, Membranoproliferative - drug therapy ; Glomerulonephritis, Membranoproliferative - metabolism ; Kidney - cytology ; Kidney - metabolism ; Leukocytes, Mononuclear - metabolism ; Male ; Medical sciences ; necrosis factor ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Neutrophils - metabolism ; Platelet Activating Factor - biosynthesis ; platelet‐activating factor ; proteinuria ; Rats ; Rats, Wistar ; Tumor Necrosis Factor-alpha - biosynthesis ; tumour</subject><ispartof>Clinical and experimental immunology, 1995-08, Vol.101 (2), p.334-340</ispartof><rights>1995 Blackwell Science Ltd, Oxford</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73</citedby><cites>FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1553248/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1553248/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3617453$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7648718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ORTÍZ, A.</creatorcontrib><creatorcontrib>ALONSO, J.</creatorcontrib><creatorcontrib>GÓMEZ‐CHIARRI, M.</creatorcontrib><creatorcontrib>LERMA, J. L.</creatorcontrib><creatorcontrib>SERON, D.</creatorcontrib><creatorcontrib>CONDOM, E.</creatorcontrib><creatorcontrib>GONZÁLEZ, E.</creatorcontrib><creatorcontrib>EGIDO, J.</creatorcontrib><title>Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis</title><title>Clinical and experimental immunology</title><addtitle>Clin Exp Immunol</addtitle><description>SUMMARY
We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF‐α and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF‐α and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular TNF‐α bioactivity coincided with maximal proteinuria. Rats treated with FN (5 mg/kg per 48 h) for 15 days had less proteinuria, glomerular and interstitial cell infiltration and glomerular PAF, TNF‐α and FN synthesis than non‐treated rats. In order to characterize further the mechanisms of action of FN, healthy rats were injected with either FN or saline. Peripheral blood mononuclear cells and neutrophils from healthy rats injected with FN secreted less TNF‐α and PAF, respectively, than those obtained from saline‐treated rats. Our data suggest that the beneficial effect of FN may be related to decreased number of glomerular leucocytes and decreased synthesis of inflammatory mediators and extracellular matrix.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Extracellular Matrix - drug effects</subject><subject>Extracellular Matrix - metabolism</subject><subject>fibronectin</subject><subject>Fibronectins - biosynthesis</subject><subject>Fibronectins - pharmacology</subject><subject>Glomerular Mesangium - drug effects</subject><subject>Glomerular Mesangium - metabolism</subject><subject>Glomerulonephritis</subject><subject>Glomerulonephritis, Membranoproliferative - drug therapy</subject><subject>Glomerulonephritis, Membranoproliferative - metabolism</subject><subject>Kidney - cytology</subject><subject>Kidney - metabolism</subject><subject>Leukocytes, Mononuclear - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>necrosis factor</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Neutrophils - metabolism</subject><subject>Platelet Activating Factor - biosynthesis</subject><subject>platelet‐activating factor</subject><subject>proteinuria</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><subject>tumour</subject><issn>0009-9104</issn><issn>1365-2249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNqVUkGO0zAUjRBoKANHQLIQQq1Eip04TswCNKomMNKosBjW1o_rtK7cOGMnZbrjCFyFFbfgEJwEh0YVbJDwxv5-77__bL0oekbwnIT1ajsnKcviJKF8TjjP5l2Fi5Th-d29aHKC7kcTjDGPOcH0YfTI-20oGWPJWXSWM1rkpJhE30tdOdso2ekGTcvlDK2UdAq88mht7E653oBDRnltG4-gWSF_aLpNqD2yNer6ne0dCgLODlc1yM66n1--gmk3gKY3yzIUP77NXqLWQKeM6gYwjNtDGLkeG9D040U5-y1fLlGw0jprdK1cIO3VyUkw2m6c7rR_HD2owXj1ZNzPo0_l5c3ifXz94d3V4uI6llnKcSwlZyuOi4JxCbICWOWSQUZ4ImmFMYGkoDzPw-dRAMZBVaSWSZ2mhSoSgDw9j94cddu-2qmVVE3nwIjW6R24g7Cgxd9IozdibfeCZFma0CIIvBgFnL3tle_ETnupjIFG2d6LPKeMEkoDcfpPIqGsSAua5CxQXx-pw6d7p-qTH4LFkBCxFUMMxBADMSREjAkRd6H56Z8vOrWOkQj48xEHL8HUDhqp_YmWMpLTLA20t0faZ23U4T8MiMXl1XBKfwFR5uDA</recordid><startdate>199508</startdate><enddate>199508</enddate><creator>ORTÍZ, A.</creator><creator>ALONSO, J.</creator><creator>GÓMEZ‐CHIARRI, M.</creator><creator>LERMA, J. L.</creator><creator>SERON, D.</creator><creator>CONDOM, E.</creator><creator>GONZÁLEZ, E.</creator><creator>EGIDO, J.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199508</creationdate><title>Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis</title><author>ORTÍZ, A. ; ALONSO, J. ; GÓMEZ‐CHIARRI, M. ; LERMA, J. L. ; SERON, D. ; CONDOM, E. ; GONZÁLEZ, E. ; EGIDO, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Extracellular Matrix - drug effects</topic><topic>Extracellular Matrix - metabolism</topic><topic>fibronectin</topic><topic>Fibronectins - biosynthesis</topic><topic>Fibronectins - pharmacology</topic><topic>Glomerular Mesangium - drug effects</topic><topic>Glomerular Mesangium - metabolism</topic><topic>Glomerulonephritis</topic><topic>Glomerulonephritis, Membranoproliferative - drug therapy</topic><topic>Glomerulonephritis, Membranoproliferative - metabolism</topic><topic>Kidney - cytology</topic><topic>Kidney - metabolism</topic><topic>Leukocytes, Mononuclear - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>necrosis factor</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Neutrophils - metabolism</topic><topic>Platelet Activating Factor - biosynthesis</topic><topic>platelet‐activating factor</topic><topic>proteinuria</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><topic>tumour</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ORTÍZ, A.</creatorcontrib><creatorcontrib>ALONSO, J.</creatorcontrib><creatorcontrib>GÓMEZ‐CHIARRI, M.</creatorcontrib><creatorcontrib>LERMA, J. L.</creatorcontrib><creatorcontrib>SERON, D.</creatorcontrib><creatorcontrib>CONDOM, E.</creatorcontrib><creatorcontrib>GONZÁLEZ, E.</creatorcontrib><creatorcontrib>EGIDO, J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and experimental immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ORTÍZ, A.</au><au>ALONSO, J.</au><au>GÓMEZ‐CHIARRI, M.</au><au>LERMA, J. L.</au><au>SERON, D.</au><au>CONDOM, E.</au><au>GONZÁLEZ, E.</au><au>EGIDO, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis</atitle><jtitle>Clinical and experimental immunology</jtitle><addtitle>Clin Exp Immunol</addtitle><date>1995-08</date><risdate>1995</risdate><volume>101</volume><issue>2</issue><spage>334</spage><epage>340</epage><pages>334-340</pages><issn>0009-9104</issn><eissn>1365-2249</eissn><coden>CEXIAL</coden><abstract>SUMMARY
We have studied the effect of therapy with plasma FN on glomerular synthesis of PAF, TNF‐α and FN, in experimental proliferative glomerulonephritis. Glomerular PAF, TNF‐α and FN production were increased in rats with nephritis. Peak glomerular PAF production preceded, while peak glomerular TNF‐α bioactivity coincided with maximal proteinuria. Rats treated with FN (5 mg/kg per 48 h) for 15 days had less proteinuria, glomerular and interstitial cell infiltration and glomerular PAF, TNF‐α and FN synthesis than non‐treated rats. In order to characterize further the mechanisms of action of FN, healthy rats were injected with either FN or saline. Peripheral blood mononuclear cells and neutrophils from healthy rats injected with FN secreted less TNF‐α and PAF, respectively, than those obtained from saline‐treated rats. Our data suggest that the beneficial effect of FN may be related to decreased number of glomerular leucocytes and decreased synthesis of inflammatory mediators and extracellular matrix.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>7648718</pmid><doi>10.1111/j.1365-2249.1995.tb08360.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9104 |
ispartof | Clinical and experimental immunology, 1995-08, Vol.101 (2), p.334-340 |
issn | 0009-9104 1365-2249 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1553248 |
source | PubMed Central (Open access) |
subjects | Animals Biological and medical sciences Extracellular Matrix - drug effects Extracellular Matrix - metabolism fibronectin Fibronectins - biosynthesis Fibronectins - pharmacology Glomerular Mesangium - drug effects Glomerular Mesangium - metabolism Glomerulonephritis Glomerulonephritis, Membranoproliferative - drug therapy Glomerulonephritis, Membranoproliferative - metabolism Kidney - cytology Kidney - metabolism Leukocytes, Mononuclear - metabolism Male Medical sciences necrosis factor Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Neutrophils - metabolism Platelet Activating Factor - biosynthesis platelet‐activating factor proteinuria Rats Rats, Wistar Tumor Necrosis Factor-alpha - biosynthesis tumour |
title | Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T11%3A36%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fibronectin%20(FN)%20decreases%20glomerular%20lesions%20and%20synthesis%20of%20tumour%20necrosis%20factor%E2%80%90alpha%20(TNF%E2%80%90%CE%B1),%20platelet%E2%80%90activating%20factor%20(PAF)%20and%20FN%20in%20proliferative%20glomerulonephritis&rft.jtitle=Clinical%20and%20experimental%20immunology&rft.au=ORT%C3%8DZ,%20A.&rft.date=1995-08&rft.volume=101&rft.issue=2&rft.spage=334&rft.epage=340&rft.pages=334-340&rft.issn=0009-9104&rft.eissn=1365-2249&rft.coden=CEXIAL&rft_id=info:doi/10.1111/j.1365-2249.1995.tb08360.x&rft_dat=%3Cproquest_pubme%3E77464144%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5390-cc96d908869cacbaad7c6a5192c4b001a2849778364aa69aeb1fc2f338e82aa73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1468384276&rft_id=info:pmid/7648718&rfr_iscdi=true |